Wells Fargo’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $333M | Buy |
744,995
+3,182
| +0.4% | +$1.48M | 0.06% | 266 |
|
|
2025
Q4 | $336M | Buy |
741,813
+24,487
| +3% | +$10.6M | 0.06% | 262 |
|
|
2025
Q3 | $281M | Buy |
717,326
+15,274
| +2% | +$6.38M | 0.05% | 295 |
|
|
2025
Q2 | $313M | Sell |
702,052
-4,117
| -0.6% | -$1.9M | 0.06% | 257 |
|
|
2025
Q1 | $342M | Buy |
706,169
+16,517
| +2% | +$7.7M | 0.08% | 237 |
|
|
2024
Q4 | $278M | Sell |
689,652
-140,568
| -17% | -$65.2M | 0.06% | 265 |
|
|
2024
Q3 | $386M | Buy |
830,220
+11,856
| +1% | +$5.7M | 0.09% | 206 |
|
|
2024
Q2 | $384M | Buy |
818,364
+50,797
| +7% | +$22M | 0.09% | 200 |
|
|
2024
Q1 | $321M | Buy |
767,567
+18,601
| +2% | +$7.86M | 0.08% | 228 |
|
|
2023
Q4 | $305M | Sell |
748,966
-31,321
| -4% | -$11.6M | 0.08% | 227 |
|
|
2023
Q3 | $271M | Sell |
780,287
-27,328
| -3% | -$9.56M | 0.08% | 225 |
|
|
2023
Q2 | $284M | Buy |
807,615
+25,507
| +3% | +$8.59M | 0.08% | 227 |
|
|
2023
Q1 | $246M | Buy |
782,108
+33,181
| +4% | +$9.95M | 0.07% | 240 |
|
|
2022
Q4 | $216M | Sell |
748,927
-29,344
| -4% | -$8.94M | 0.06% | 259 |
|
|
2022
Q3 | $225M | Sell |
778,271
-21,431
| -3% | -$6.17M | 0.07% | 242 |
|
|
2022
Q2 | $225M | Sell |
799,702
-51,380
| -6% | -$13.8M | 0.07% | 243 |
|
|
2022
Q1 | $222M | Buy |
851,082
+5,278
| +0.6% | +$1.25M | 0.06% | 276 |
|
|
2021
Q4 | $186M | Sell |
845,804
-285,787
| -25% | -$55.6M | 0.05% | 310 |
|
|
2021
Q3 | $205M | Sell |
1,131,591
-41,789
| -4% | -$8.16M | 0.05% | 399 |
|
|
2021
Q2 | $237M | Sell |
1,173,380
-56,679
| -5% | -$11.9M | 0.05% | 360 |
|
|
2021
Q1 | $264M | Sell |
1,230,059
-75,085
| -6% | -$16.5M | 0.06% | 318 |
|
|
2020
Q4 | $308M | Sell |
1,305,144
-170,206
| -12% | -$39.1M | 0.07% | 256 |
|
|
2020
Q3 | $401M | Sell |
1,475,350
-51,698
| -3% | -$14.3M | 0.11% | 177 |
|
|
2020
Q2 | $443M | Buy |
1,527,048
+187,264
| +14% | +$50.8M | 0.13% | 159 |
|
|
2020
Q1 | $319M | Buy |
1,339,784
+14,132
| +1% | +$3.24M | 0.11% | 187 |
|
|
2019
Q4 | $290M | Sell |
1,325,652
-44,735
| -3% | -$9.05M | 0.08% | 249 |
|
|
2019
Q3 | $232M | Sell |
1,370,387
-111,609
| -8% | -$19.7M | 0.07% | 296 |
|
|
2019
Q2 | $272M | Sell |
1,481,996
-95,420
| -6% | -$16.7M | 0.08% | 245 |
|
|
2019
Q1 | $290M | Sell |
1,577,416
-332,587
| -17% | -$61.4M | 0.09% | 221 |
|
|
2018
Q4 | $317M | Sell |
1,910,003
-241,710
| -11% | -$41.9M | 0.11% | 192 |
|
|
2018
Q3 | $415M | Buy |
2,151,713
+64,205
| +3% | +$11.4M | 0.12% | 173 |
|
|
2018
Q2 | $355M | Buy |
2,087,508
+82,811
| +4% | +$12.8M | 0.11% | 195 |
|
|
2018
Q1 | $327M | Sell |
2,004,697
-122,395
| -6% | -$20M | 0.1% | 208 |
|
|
2017
Q4 | $319M | Buy |
2,127,092
+149,823
| +8% | +$22.2M | 0.09% | 218 |
|
|
2017
Q3 | $301M | Buy |
1,977,269
+61,042
| +3% | +$9.19M | 0.09% | 218 |
|
|
2017
Q2 | $247M | Buy |
1,916,227
+83,314
| +5% | +$10M | 0.08% | 263 |
|
|
2017
Q1 | $200M | Buy |
1,832,913
+301,675
| +20% | +$26.6M | 0.07% | 307 |
|
|
2016
Q4 | $113M | Sell |
1,531,238
-109,958
| -7% | -$8.95M | 0.04% | 468 |
|
|
2016
Q3 | $143M | Sell |
1,641,196
-186,554
| -10% | -$17.6M | 0.05% | 390 |
|
|
2016
Q2 | $157M | Sell |
1,827,750
-151,467
| -8% | -$13.1M | 0.06% | 339 |
|
|
2016
Q1 | $157M | Sell |
1,979,217
-631,608
| -24% | -$57.1M | 0.06% | 338 |
|
|
2015
Q4 | $329M | Buy |
2,610,825
+1,440,201
| +123% | +$174M | 0.13% | 178 |
|
|
2015
Q3 | $122M | Sell |
1,170,624
-103,881
| -8% | -$13.3M | 0.05% | 392 |
|
|
2015
Q2 | $157M | Sell |
1,274,505
-22,669
| -2% | -$2.86M | 0.06% | 350 |
|
|
2015
Q1 | $153M | Sell |
1,297,174
-367,769
| -22% | -$44.1M | 0.06% | 352 |
|
|
2014
Q4 | $198M | Buy |
1,664,943
+374,809
| +29% | +$42.2M | 0.08% | 296 |
|
|
2014
Q3 | $145M | Buy |
1,290,134
+616,976
| +92% | +$58.7M | 0.06% | 354 |
|
|
2014
Q2 | $63.7M | Sell |
673,158
-1,058,191
| -61% | -$74.2M | 0.03% | 661 |
|
|
2014
Q1 | $122M | Sell |
1,731,349
-454,574
| -21% | -$36M | 0.05% | 410 |
|
|
2013
Q4 | $162M | Buy |
2,185,923
+179,426
| +9% | +$12.5M | 0.07% | 316 |
|
|
2013
Q3 | $152M | Buy |
2,006,497
+103,266
| +5% | +$8.22M | 0.07% | 314 |
|
|
2013
Q2 | $152M | Buy |
+1,903,231
| New | +$140M | 0.08% | 298 |
|
Other funds holding VRTX
VCM
VPM
Wells Fargo's VRTX Position: Q1 2026 in Review
Wells Fargo increased its Vertex Pharmaceuticals (VRTX) stake by 0.43% in Q1 2026, buying an estimated $1.48M and bringing the position to 744,995 shares worth $333M. The position accounts for 0.06% of the portfolio, ranked #266.
Wells Fargo first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $443M in Q2 2020. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Wells Fargo held 744,995 shares of Vertex Pharmaceuticals worth $333M as of Q1 2026.
- Wells Fargo bought 3,182 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.48M.
- Vertex Pharmaceuticals made up 0.06% of Wells Fargo's portfolio in Q1 2026, its #266 holding.
- Wells Fargo first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Vertex Pharmaceuticals position peaked at $443M in Q2 2020.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.